Tag - pregnancy

26May

Best practices to boost postpartum appointments

RELATE DISCUSS the importance of the postpartum visit with your patient during her pregnancy DISTRIBUTE the Texas Children’s Health Plan Postpartum Checklist to your patients in the late third trimester MOTIVATE INCLUDE Texas Children’s Health Plan postpartum visit information in your practice welcome packet INFORM your patients about the Texas Children’s Health Plan value-added service they qualify for by attending their postpartum visit TRACK your appointment success rate (the percentage of your patients who get the postpartum check between 21-56 days) SET A DATE SCHEDULE the postpartum visit...

By OB/GYNs, , 0 CommentsRead more...
24Mar

Substance Use and Pregnancy

According to a 2017 report by Texas Health and Human Services, the most commonly used substances by Texas women include stimulants, hallucinogens, opioids and synthetics, and alcohol. While use and misuse are an area of clinical concern when seen in any patient, it is of particular concern when seen in in the context of pregnancy. Prevention is a key intervention; for patients already using, intervention can occur on many levels including residential and ambulatory detoxification, outpatient and residential treatment settings,...

By OB/GYNs, , , 0 CommentsRead more...
24May

The Texas Clinician’s Postpartum Depression Toolkit

A new resource for screening, diagnosis and treatment of postpartum depression. Click here to view this helpful resource for postpartum depression: http://www.texaschildrenshealthplan.org/sites/default/files/pdf/the_texas_clinicians_postpartum_depression_toolkit%20FINAL.pdf

By OB/GYNs, , , , 0 CommentsRead more...
05Apr

Cesarean Delivery

This article presents new research and strategies to safely reduce the rate of primary Cesarean delivery. One out of three deliveries is by Cesarean.  In certain situations, Cesarean can be life-saving for both mother and baby.  But Cesarean deliveries aslo carry greater risks for mothers—research has shown that women who deliver their first baby by cesarean are more likely to need blood transfusions and be admitted to the ICU than women who have a vaginal delivery.  In addition, after that first...

By OB/GYNs, , , , , 0 CommentsRead more...
15Mar

Zika Virus and Pregnant Women

Everyone is talking about Zika! The virus is transmitted through infected mosquitos. Mexico, the Caribbean, Central America, along with parts of South America, have documented transmission of the virus and pregnant women who live in or travel to these areas are at risk of infection. Infection during pregnancy may or may not be accompanied by symptoms and has been associated with microcephaly. No treatment is available at this time. The most important thing to remember is that our knowledge about several...

By OB/GYNs, , , , , , 0 CommentsRead more...
23Dec

Vaccines and Pregnancy

By Dr. Lisa Hollier, MD MPH Chief Medical Officer Texas Children’s Health Plan Professor, Maternal-Fetal Medicine Director, Health Policy Division, Baylor College of Medicine Pregnant women, along with their fetuses, are particularly vulnerable to vaccine-preventable disease-related complications. The Centers for Disease Control and Prevention (CDC) have made recommendations for adult vaccines and there are two that are directly recommended for administration during pregnancy, four are recommended in pregnancy based on additional risk factors, and two are specifically recommended during the postpartum period (see table)....

By OB/GYNs, , , , , , , , , , , , , , 0 CommentsRead more...
01Sep

Provider Alert! Preventing Pre-Term Pregnancies

To: All Providers Subject: Effective September 1, 2015 all Progesterone therapy will require a pre-authorization from Texas Children’s Health Plan. Claims billed using the branded Makena will no longer require a U1 modifier. Pre-authorized use of Makena (hydroxyprogesterone caproate injection) will need to be submitted as J1725 with the appropriate NDC information as required on all claims. Claims billed using the compounded 17-P therapy will now require the U1 modifier. Pre-authorized use of 17-P will need to be submitted as J1725 with the...

By OB/GYNs, Provider Alert, , , , , , , 0 CommentsRead more...